Silber Allan C

Silber Allan C serves as the Executive Chairman of POINT Biopharma Global Inc., a firm focused on innovative therapies in the healthcare sector. His recent financial disclosures, covering the period from November 7, 2023, to December 27, 2023, include five public filings. Notably, the largest disclosed transaction during this time involved an action valued at approximately $3.6 million related to POINT Biopharma (PNT), reflecting a concentrated investment approach in the healthcare sector.